Kiran Mazumdar-Shaw, the founder of Biocon, indicated that she was preparing for a gradual leadership transition over the next five years. Her niece, Claire Mazumdar, is expected to eventually take over as chairman of Biocon.
Ms. Claire currently serves as the CEO of Bicara Therapeutics, a US-based biotech company, where she has led the business since 2020. Bicara Therapeutics is a publicly traded, clinical-stage biotech company primarily owned by institutional investors, with significant backing from its founder, Biocon Ltd, according to market sources.
Published – May 5, 2026 8:36 PM IST
